Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function

Journal of Applied Physiology

Volumn 110, Issue 1, 2011, Pages 188-198

  Vanderpool, Rebecca R ^a   Kim, Ah Ram ^a   Molthen, Robert ^b   Chesler, Naomi C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arterial biomechanics; Impedance; Pulmonary circulation; Y27632

Indexed keywords

RHO KINASE;

ADAPTATION; ANIMAL; ANOXIA; ARTICLE; C57BL MOUSE; DRUG ANTAGONISM; MALE; MOUSE; PATHOPHYSIOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; RADIOGRAPHY; VASOCONSTRICTION; YOUNG MODULUS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; ELASTIC MODULUS; HYPERTENSION, PULMONARY; MALE; MICE; MICE, INBRED C57BL; PULMONARY ARTERY; RHO-ASSOCIATED KINASES; VASOCONSTRICTION;

EID: 79251509290     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00533.2010     Document Type: Article

References (65)

1. Belknap J, Orton E, Ensley B, Tucker A, Stenmark K. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. Am J Respir Cell Mol Biol 16: 366-371, 1997.
2. Benumof J. One-lung ventilation and hypoxic pulmonary vasoconstriction: implications for anesthetic management. Anesth Analg 64: 821-833, 1985.
3. Bogaard H, Natarajan R, Henderson S, Long C, Kraskauskas D, Smithson L, Ockaili R, McCord J, Voelkel N. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120: 1951-1960, 2009.
4. Bogren H, Klipstein R, Mohiaddin R, Firmin D, Underwood S, Rees R, Longmore D. Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J 118: 990-999, 1989.
5. Castelain V, Chemla D, Humbert M, Sitbon O, Simonneau G, Lecarpentier Y, Hervé P. Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension. Am J Respir Crit Care Med 165: 338-340, 2002.
6. Champion H, Michelakis E, Hassoun P. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 120: 992-1007, 2009.
7. Doyle B, Callanan A, Burke P, Grace P, Walsh M, Vorp D, Mc- Gloughlin T. Vessel asymmetry as an additional diagnostic tool in the assessment of abdominal aortic aneurysms. J Vasc Surg 49: 443-454, 2009.
8. Drexler ES, Quinn TP, Slifka AJ, McCowan CN, Bischoff JE, Wright JE, Ivy DD, Shandas R. Comparison of mechanical behavior among the extrapulmonary arteries from rats. J Biomech 40: 812-819, 2007.
9. Estrada K, Chesler N. Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia. Biomech Model Mechanobiol 8: 263-272, 2009.
10. Fagan K, Oka M, Bauer N, Gebb S, Ivy D, Morris K, McMurtry I. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L656-L664, 2004.
11. Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart 91: 391-392, 2005.
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503, 2003.
13. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani M, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 30: 394-403, 2009.
14. Gan C, Lankhaar J, Westerhof N, Marcus J, Becker A, Twisk J, Boonstra A, Postmus P, Vonk-Noordegraaf A. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 132: 1906-1912, 2007.
15. Gerasimovskaya E, Ahmad S, White C, Jones P, Carpenter T, Stenmark K. Extracellular ATP is an autocrine/paracrine regulator of hypoxiainduced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 277: 44638-44650, 2002.
16. Gere JM, Timoshenko SP. Mechanics of Materials. Boston, MA: PWS Pub, 1997, p. xvi, 912 p.
17. Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 57: 542-554, 1976.
18. Homma N, Nagaoka T, Karoor V, Imamura M, Taraseviciene- Stewart L, Walker L, Fagan K, McMurtry I, Oka M. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol 295: L71-L78, 2008.
19. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 97: 185-191, 2005.
20. Isaka M, Sakuma I, Imamura M, Makino Y, Fukushima S, Nakai K, Shiiya N, Kenmotsu O, Kitabatake A, Yasuda K. Experimental studies on artificial blood usage for hemodilution during cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 11: 238-244, 2005.
21. Ishikura K, Yamada N, Ito M, Ota S, Nakamura M, Isaka N, Nakano T. Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 70: 174-178, 2006.
22. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57: 976-983, 2000.
23. Jardim C, Rochitte C, Humbert M, Rubenfeld G, Jasinowodolinski D, Carvalho C, Souza R. Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study. Eur Respir J 29: 476-481, 2007.
24. Karau K, Johnson R, Molthen R, Dhyani A, Haworth S, Hanger C, Roerig D, Dawson C. Microfocal X-ray CT imaging and pulmonary arterial distensibility in excised rat lungs. Am J Physiol Heart Circ Physiol 281: H1447-H1457, 2001.
25. Karau K, Molthen R, Dhyani A, Haworth S, Hanger C, Roerig D, Johnson R, Dawson C. Pulmonary arterial morphometry from microfocal X-ray computed tomography. Am J Physiol Heart Circ Physiol 281: H2747-H2756, 2001.
26. Kobs RW, Chesler NC. The mechanobiology of pulmonary vascular remodeling in the congenital absence of eNOS. Biomech Model Mechanobiol 5: 217-225, 2006.
27. Kobs RW, Muvarak NE, Eickhoff JC, Chesler NC. Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. Am J Physiol Heart Circ Physiol 288: H1209-H1217, 2005.
28. Lammers SR, Kao PH, Qi HJ, Hunter K, Lanning C, Albietz J, Hofmeister S, Mecham R, Stenmark KR, Shandas R. Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. Am J Physiol Heart Circ Physiol 295: H1451-H1459, 2008.
29. Lejeune P, Deloof T, Leeman M, Mélot C, Naeije R. Multipoint pulmonary vascular pressure/flow relationships in hypoxic and in normoxic dogs: effects of nitrous oxide with and without cyclooxygenase inhibition. Anesthesiology 68: 92-99, 1988.
30. Li F, Xia W, Yuan S, Sun R. Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease. Pediatr Cardiol 30: 363-366, 2009.
31. Linehan J, Haworth S, Nelin L, Krenz G, Dawson C. A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J Appl Physiol 73: 987-994, 1992.
32. Mahapatra S, Nishimura R, Sorajja P, Cha S, McGoon M. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 47: 799-803, 2006. (Pubitemid 43243104)
33. Mathers J, Benumof J, Wahrenbrock E. General anesthetics and regional hypoxic pulmonary vasoconstriction. Anesthesiology 46: 111-114, 1977. (Pubitemid 8035218)
34. McLaughlin V, Archer S, Badesch D, Barst R, Farber H, Lindner J, Mathier M, McGoon M, Park M, Rosenson R, Rubin L, Tapson V, Varga J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society,; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53: 1573-1619, 2009.
35. McMurtry I, Abe K, Ota H, Fagan K, Oka M. Rho kinase-mediated vasoconstriction in pulmonary hypertension. Adv Exp Med Biol 661: 299-308, 2010.
36. Merklinger SL, Wagner RA, Spiekerkoetter E, Hinek A, Knutsen RH, Kabir MG, Desai K, Hacker S, Wang L, Cann GM, Ambartsumian NS, Lukanidin E, Bernstein D, Husain M, Mecham RP, Starcher B, Yanagisawa H, Rabinovitch M. Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circ Res 97: 596-604, 2005.
37. Meyrick B, Reid L. Pulmonary hypertension. Anatomic and physiologic correlates. Clin Chest Med 4: 199-217, 1983.
38. Milnor WR. Hemodynamics. Baltimore, MD: Williams and Wilkins, 1989, p. 419.
39. Molthen RC, Karau KL, Dawson CA. Quantitative models of the rat pulmonary arterial tree morphometry applied to hypoxia-induced arterial remodeling. J Appl Physiol 97: 2372-2384, 2004.
40. Mortimer H, Peacock A, Kirk A, Welsh D. p38 MAP kinase: essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation. Pulm Pharmacol Ther 20: 718-725, 2007.
41. Naeije R. Pulmonary vascular function. In: Pulmonary Circulation: Diseases and Their Treatment, edited by Peacock AJ and Rubin LJ. London: Arnold, 2004, p. 3-11.
42. Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 171: 494-499, 2005.
43. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, Oka M. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287: L665-L672, 2004.
44. Nichols WW, O'Rourke MF, Hartley C, McDonald DA. McDonald's Blood Flow in Arteries: Theoretical, Experimental, and Clinical Principles. London: Arnold, 2005.
45. O'Flynn P, O'Sullivan G, Pandit A. Geometric variability of the abdominal aorta and its major peripheral branches. Ann Biomed Eng 38: 824-840, 2010.
46. Oka M, Homma N, Taraseviciene-Stewart L, Morris K, Kraskauskas D, Burns N, Voelkel N, McMurtry I. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 100: 923-929, 2007.
47. Phan S. The myofibroblast in pulmonary fibrosis. Chest 122: 286S-289S, 2002.
48. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol Heart Circ Physiol 236: H818-H827, 1979.
49. Saeed M, Hartmann A, Bing R. Inhibition of vasoactive agents by perfluorochemical emulsion. Life Sci 40: 1971-1979, 1987.
50. Sanz J, Kariisa M, Dellegrottaglie S, Prat-González S, Garcia M, Fuster V, Rajagopalan S. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2: 286-295, 2009.
51. Schwenke D, Pearson J, Kangawa K, Umetani K, Shirai M. Changes in macrovessel pulmonary blood flow distribution following chronic hypoxia: assessed using synchrotron radiation microangiography. J Appl Physiol 104: 88-96, 2008.
52. Schwenke D, Pearson J, Umetani K, Kangawa K, Shirai M. Imaging of the pulmonary circulation in the closed-chest rat using synchrotron radiation microangiography. J Appl Physiol 102: 787-793, 2007.
53. Stenmark K, Meyrick B, Galie N, Mooi W, McMurtry I. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 297: L1013-L1032, 2009.
54. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99: 675-691, 2006.
55. Stenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal? Circ Res 97: 95-98, 2005.
56. Tabima D, Chesler N. The effects of vasoactivity and hypoxic pulmonary hypertension on extralobar pulmonary artery biomechanics. J Biomech 43: 1864-1869, 2010.
57. Tada Y, Laudi S, Harral J, Carr M, Ivester C, Tanabe N, Takiguchi Y, Tatsumi K, Kuriyama T, Nichols W, West J. Murine pulmonary response to chronic hypoxia is strain specific. Exp Lung Res 34: 313-323, 2008.
58. Tuchscherer HA, Vanderpool RR, Chesler NC. Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships. J Biomech 40: 993-1001, 2007.
59. Tuchscherer HA, Webster EB, Chesler NC. Pulmonary vascular resistance and impedance in isolated mouse lungs: effects of pulmonary emboli. Ann Biomed Eng 34: 660-668, 2006.
60. Vanderpool RR, Naeije R, Chesler NC. Impedance in isolated mouse lungs for the determination of site of action of vasoactive agents and disease. Ann Biomed Eng 38: 1854-1861, 2010.
61. Voelkel N, Quaife R, Leinwand L, Barst R, McGoon M, Meldrum D, Dupuis J, Long C, Rubin L, Smart F, Suzuki Y, Gladwin M, Denholm E, Gail D. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114: 1883-1891, 2006.
62. Von Bethmann AN, Brasch F, Nusing R, Vogt K, Volk HD, Muller KM, Wendel A, Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 157: 263-272, 1998. (Pubitemid 28071291)
63. Westerhof N, Stergiopulos N, Noble MIM. Snapshots of Hemodynamics An Aid for Clinical Research and Graduate Education. New York: Springer, 2004, p. 192.
64. Yen R, Zhuang F, Fung Y, Ho H, Tremer H, Sobin S. Morphometry of cat's pulmonary arterial tree. J Biomech Eng 106: 131-136, 1984.
65. Zhao J, Day J, Yuan Z, Gregersen H. Regional arterial stress-strain distributions referenced to the zero-stress state in the rat. Am J Physiol Heart Circ Physiol 282: H622-H629, 2002.